| Fund ID | 805-6854921828 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | Yes |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 100% |
| Fund | Type | Gross assets |
|---|---|---|
| Acon Latin America Opportunities Fund IV, L.P. | Private Equity | $407M |
| Acon Bios Investors, L.P. | Private Equity | $295.3M |
| Acon Latin America Opportunities Fund V, L.P. | Private Equity | $220.6M |
Acon Injectable Investors II, L.P. reports $10.1 million in gross assets, among the top 77% of private funds by size.
The stated minimum investment is $500,000.
Acon Injectable Investors II, L.P. is managed by Acon Latam Management, L.L.C.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.